WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Eric Y. Hsu
Partner
Corporate
Palo Alto
ehsu@wsgr.com

D650-849-3305

Download vCard
LinkedIn
Open PDF

Eric Hsu is a corporate and securities partner in the life sciences practice at Wilson Sonsini Goodrich & Rosati. He represents emerging growth companies in areas such as medical devices, digital health, and biotechnology. Eric advises public and private companies on general corporate matters, mergers and acquisitions, initial public offerings, public company reporting, strategic partnerships, venture capital financings, and private equity and debt financings.

During law school, Eric served as an extern with the UC Davis Technology Transfer Office, Innovation Access, where he performed threshold patent analysis and drafted contracts and licenses. He also assisted service members in the Armed Forces as an extern for the United States Air Force Judge Advocate General at Travis Air Force Base, and worked as an extern for Justice Nathan Mihara of the California Court of Appeal for the Sixth District on a wide variety of civil and criminal appeals.

Prior to attending law school, Eric worked in flu vaccine research and development for MedImmune Inc.

Experience

Eric Hsu is a corporate and securities partner in the life sciences practice at Wilson Sonsini Goodrich & Rosati. He represents emerging growth companies in areas such as medical devices, digital health, and biotechnology. Eric advises public and private companies on general corporate matters, mergers and acquisitions, initial public offerings, public company reporting, strategic partnerships, venture capital financings, and private equity and debt financings.

During law school, Eric served as an extern with the UC Davis Technology Transfer Office, Innovation Access, where he performed threshold patent analysis and drafted contracts and licenses. He also assisted service members in the Armed Forces as an extern for the United States Air Force Judge Advocate General at Travis Air Force Base, and worked as an extern for Justice Nathan Mihara of the California Court of Appeal for the Sixth District on a wide variety of civil and criminal appeals.

Prior to attending law school, Eric worked in flu vaccine research and development for MedImmune Inc.

Education
  • J.D., UC Davis School of LawOrder of the Coif; Neumiller Chair, Moot Court Board; Recipient, Joseph and Jan Cutter Lake Scholarship for Academic Excellence; Recipient, Witkin Award for Academic Excellence, Trademarks; Certificate in Public Interest
  • B.S., Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles
Honors
  • Named to the 2018 edition of the "Rising Stars" list published by Northern California Super Lawyers
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., UC Davis School of LawOrder of the Coif; Neumiller Chair, Moot Court Board; Recipient, Joseph and Jan Cutter Lake Scholarship for Academic Excellence; Recipient, Witkin Award for Academic Excellence, Trademarks; Certificate in Public Interest
  • B.S., Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles
Honors
  • Named to the 2018 edition of the "Rising Stars" list published by Northern California Super Lawyers
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office
Focus Areas
  • Corporate
  • Corporate Life Sciences
  • Life Sciences
  • Medical Devices
Recent Insights
Client Highlights
Wilson Sonsini Advises Nalu Medical on $104 Million Equity Financing
On February 17, 2022, Nalu Medical, Inc., a private company focused on innovative and minimally invasive solutions for chronic neuropathic pain, announced a $104 million equity financing. The round was led by new investors MVM Partners and Gilde Healthcare. New investors Pura Vida Investments and Aperture Venture Partners, as well as existing investors Advent Life Sciences, Decheng Capital, Endeavour Vision, and Longitude Capital, also participated in the round. The proceeds from this financing are intended to be used for scaling commercial operations to accelerate growth, continued expansion of clinical evidence, and continuing product development, in addition to other general corporate purposes. Wilson Sonsini Goodrich & Rosati advised Nalu Medical on the transaction.
Learn More
Newsletters
The Life Sciences Report – June 2021
In this issue, we feature articles on managing IP development and capture at growing medtech start-ups, life sciences venture financings in which firm clients participated during 2020, the U.S.-Japan Healthcare Connection's virtual conference on the coming revolution in healthcare, and the Biden administration's signing of two bipartisan bills that aim to promote drug competition and reduce prescription drug prices, as well as a summary of select recent life sciences client highlights.
Learn More
View All
Recent Events
Affiliated Programs
MedTech Innovator Radar Forum 2026
Wilson Sonsini is proud to support @MedTech Innovator Radar Forum April 7-9 2026, in Manhattan Beach, CA.
Learn More
Affiliated Programs
BioTools Innovator 2025 Capstone Event
Wilson Sonsini is proud to be an event sponsor for the Biotools Innovator Capstone Event on November 18th. The BioTools Innovator Capstone is the premier showcase for innovation in life science tools and diagnostics, bringing together leading pharma and biotech startups to present their groundbreaking technologies to a panel of judges, including Wilson Sonsini partners, Eric Hsu, Ingo Hardt, Marty Waters, and Bu Yin.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.